Overview of the Study Population
| Characteristic | Female | Male | P Value |
|---|---|---|---|
| Patients, n | 10,541 (57.1%) | 7,915 (42.9%) | |
| Patients' age in years, mean (SD) | 43.4 (23.1) | 42.3 (23.9) | <0.001§ |
| Patient years,* n | 78,954 (52.3%) | 75,734 (47.7%) | |
| Unique EoC, n | 21,025 (61.4%) | 13,243 (38.6%) | |
| EoC with intervention | |||
| No intervention | 3,218 (15.3%) | 1,827 (13.8) | |
| ≥1 intervention | 17,807 (84.7%) | 11,416 (86.2%) | <0.001† |
| EoC with final diagnosis | |||
| Disease diagnosis | 7,470 (35.5%) | 4,924 (37.2%) | 0.002† |
| Symptom diagnosis | 13,555 (64.5%) | 8,319 (62.8%) | |
| Encounters within an EoC | |||
| 1 encounter | 13,619 (64.8%) | 8,697 (65.7%) | 0.090† |
| >1 encounter | 7,406 (35.2%) | 4,546 (34.3%) | |
| RFE per EoC | |||
| 1 RFE | 14,739 (70.1%) | 9,839 (74.3%) | <0.001† |
| >1 RFE | 6,286 (29.9%) | 3,404 (25.7%) | |
| EoC with comorbidities, n | 8,282 (39.4%) | 5,295 (43.7%) | 0.271† |
| Cardiovascular disease | 5,741 (27.3%) | 3,827 (28.9%) | 0.001† |
| Asthma and/or COPD | 3,106 (14.8%) | 1,998 (15.1%) | 0.427† |
| Malignancies | 1,684 (8.0%) | 979 (7.4%) | 0.038† |